Zydus Cadila gets USFDA nod to Fluphenazine Hydrochloride Tablets
Ahmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg (US RLD: Prolixin Tablets). This medication is used to treat symptoms of a certain type of mental/mood condition (schizophrenia). Fluphenazine belongs to a class of...
Ahmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg (US RLD: Prolixin Tablets).
This medication is used to treat symptoms of a certain type of mental/mood condition (schizophrenia).
Fluphenazine belongs to a class of medications called phenothiazines and is also referred to as a neuroleptic.
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
The group now has 318 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.
Read also: Zydus Cadila introduces scratch code in critical drug packs, starts with Remdac, Virafin
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd